Sharon S. Ehrmeyer
Sharon S. Ehrmeyer has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Ronald H. Laessig
University of Wisconsin Medical School
5 shared publicationsR. H. Laessig
University of Wisconsin, Department of Pathology and Laboratory Medicine, Madison, WI 53706, USA
1 shared publication- RH Laessig
Department of Pathology, University of Wisconsin, Madison 53706-1572, USA
1 shared publication Ronald H Laessig
State Laboratory of Hygiene, Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI 53706
1 shared publicationRonald H. Laessig
1 shared publication
Latest Publications
- 1 February 2004
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 9 (3) , 145-147
Is CLIA 2003 the quality alliance envisioned between manufacturers, laboratory professionals, and regulatory agencies?
- 1 February 2004
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 9 (3) , 145-147
Is CLIA 2003 the quality alliance envisioned between manufacturers, laboratory professionals, and regulatory agencies?
- 1 November 2002
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 7 (11) , 450-454
A quality systems approach for identifying and controlling sources of error with point of care testing devices
- 1 November 2002
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 7 (11) , 450-454
A quality systems approach for identifying and controlling sources of error with point of care testing devices
- 8 May 2001
- Published by Elsevier in Clinica Chimica Acta
- Vol. 307 (1-2) , 95-99
Electronic “Quality Control” (EQC): is it just for unit use devices?
- 8 May 2001
- Published by Elsevier in Clinica Chimica Acta
- Vol. 307 (1-2) , 95-99
Electronic “Quality Control” (EQC): is it just for unit use devices?
- 1 May 2001
- Vol. 307 (1)
Electronic "Quality Control" (EQC): is it just for unit use devices?
- 5 September 2000
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 5 (9) , 360-362
Total quality management in hematology
- 5 September 2000
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 5 (9) , 360-362
Total quality management in hematology
- 2 September 1999
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 4 (9-10) , 419-422
Point-of-care testing: Implementation and practice of cost-effective total quality management
- 2 September 1999
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 4 (9-10) , 419-422
Point-of-care testing: Implementation and practice of cost-effective total quality management
- 3 March 1999
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 4 (3) , 93-98
The American (USA) perspective six years after implementation of CLIA'88 (Federal) regulations
- 3 March 1999
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 4 (3) , 93-98
The American (USA) perspective six years after implementation of CLIA'88 (Federal) regulations
- 1 January 1999
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 59 (7) , 563-567
Effect of legislation (CLIA'88) on setting quality specifications for US laboratories
The Clinical Laboratory Improvement Amendments of 1988 (CLIA'88) mandated, in response to concern over the perceived quality of clinical laboratory testing, universal regulation for all testing sites in the USA, including previously unregulated sites in physician offices. The intent of CLIA'88 is to ensure quality of testing through a combination of total quality management and mandated minimum quality practices. CLIA also defines, intentionally or unintentionally, through its proficiency testing requirements, intralaboratory performance standards. Meeting these requirements has been a prime motivator in improving laboratory performance. Seven years after the implementation of CLIA'88, the percentage of laboratories passing proficiency testing has increased and most laboratories have implemented quality practices.
- 1 January 1999
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 59 (7) , 563-567
Effect of legislation (CLIA'88) on setting quality specifications for US laboratories
The Clinical Laboratory Improvement Amendments of 1988 (CLIA'88) mandated, in response to concern over the perceived quality of clinical laboratory testing, universal regulation for all testing sites in the USA, including previously unregulated sites in physician offices. The intent of CLIA'88 is to ensure quality of testing through a combination of total quality management and mandated minimum quality practices. CLIA also defines, intentionally or unintentionally, through its proficiency testing requirements, intralaboratory performance standards. Meeting these requirements has been a prime motivator in improving laboratory performance. Seven years after the implementation of CLIA'88, the percentage of laboratories passing proficiency testing has increased and most laboratories have implemented quality practices.
- Open Access
- 1 September 1997
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 43 (9) , 1610-1617
Application of the Department of Health and Human Services proposed waived status requirements for in vitro diagnostic testing devices: case study
The CLIA’88 classified all clinical laboratory testing as waived, moderate, or high complexity. The eight original waived tests were characterized as simple, accurate, error-free, risk-free, and suitable for home use by nonlaboratory professionals. The subjective nature of the classification process was challenged immediately. The Clinical Laboratory Improvement Advisory Committee asked the CDC and the Health Care Financing Administration to develop objective criteria that included assessment of performance by field-test and in-house data. We examined the efficacy of the CDC protocol with empirical data from the HemoCue B-Hemoglobin Test System® submission, to assess operator competency, intra-/interoperator and between-site imprecision, and accuracy. Non-laboratory-trained operators demonstrated 2–3% imprecision (40–200 g/L). Accuracy studies yielded a slope of 1.01, an intercept of 3.53 g/L, and r of 1.00 (52–230 g/L). Results met the protocol’s Tonks’ criterion for imprecision (less than one-fourth of the reference range).
- 1 September 1997
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 43 (9) , 1610-1617
Open AccessApplication of the Department of Health and Human Services proposed waived status requirements for in vitro diagnostic testing devices: case study
The CLIA’88 classified all clinical laboratory testing as waived, moderate, or high complexity. The eight original waived tests were characterized as simple, accurate, error-free, risk-free, and suitable for home use by nonlaboratory professionals. The subjective nature of the classification process was challenged immediately. The Clinical Laboratory Improvement Advisory Committee asked the CDC and the Health Care Financing Administration to develop objective criteria that included assessment of performance by field-test and in-house data. We examined the efficacy of the CDC protocol with empirical data from the HemoCue B-Hemoglobin Test System® submission, to assess operator competency, intra-/interoperator and between-site imprecision, and accuracy. Non-laboratory-trained operators demonstrated 2–3% imprecision (40–200 g/L). Accuracy studies yielded a slope of 1.01, an intercept of 3.53 g/L, and r of 1.00 (52–230 g/L). Results met the protocol’s Tonks’ criterion for imprecision (less than one-fourth of the reference range).
- 17 July 1996
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 1 (4) , 171-175
Quality (r)evolution - guidelines and practical implementation of quality management: the U.S. perspective
- 17 July 1996
- Published by Springer Nature in Accreditation and Quality Assurance
- Vol. 1 (4) , 171-175
Quality (r)evolution - guidelines and practical implementation of quality management: the U.S. perspective